GENEVA, Oct. 27 -- XELLIA PHARMACEUTICALS APS (Dalslandsgade 11DK-2300 KOBENHAVN S) filed a patent application (PCT/EP2025/059285) for "CISATRACURIUM FORMULATION" on Apr 04, 2025. With publication no. WO/2025/219118, the details related to the patent application was published on Oct 23, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): JASPRICA, Ivona (Xellia d.o.o. Slavonska avenija 24/6,HR-10000 ZAGREB)
Abstract: The present disclosure is generally directed to storage stable formulations of cisatarcurium. A ready-to-administer aqueous formulation is provided comprising cisatracurium or a ph...